Test Price
2,800 AED✅ Home Collection Available
SLC12A3 Gene Gitelman Syndrome Genetic Test in UAE
Executive Summary & Core Metrics
Accurate molecular confirmation of Gitelman syndrome via next-generation sequencing of the SLC12A3 gene, delivering >99.9% analytical sensitivity for inherited salt-losing tubulopathy diagnosis.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SLC12A3 gene NGS test detects pathogenic variants responsible for Gitelman syndrome, a hereditary salt‑losing renal tubulopathy, with high‑throughput sequencing for comprehensive variant identification. This single‑gene analysis provides full exon and intronic coverage to confirm the molecular diagnosis and guide clinical management.
| Feature | Our NGS Test | Closest Alternative (Sanger) |
|---|---|---|
| Precision | >99.9% analytical sensitivity, full gene coverage | ~95% for targeted regions; may miss deep intronic variants |
| Methodology | Next Generation Sequencing (NGS) with copy number analysis | Sanger sequencing of selected exons only |
| Turnaround Time | 3 – 4 Weeks (ISO‑certified lab) | Often 6 – 8 Weeks |
Physician Insight & Safety Protocols
“This comprehensive NGS analysis of SLC12A3 offers definitive molecular evidence for Gitelman syndrome diagnosis. However, results must always be correlated with serum electrolyte levels, renal function markers, and a detailed family pedigree. Never adjust prescribed therapy without direct consultation with your treating nephrologist or genetic specialist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Advisory Notice
Medication Caution
Do not discontinue prescribed potassium/magnesium supplements or diuretic agents without explicit instruction from your treating physician. Abrupt changes can precipitate dangerous electrolyte disturbances.
Exclusion Criteria & Emergency Red Flags
- Active febrile illness or acute kidney injury – reschedule collection.
- Known bleeding disorder or therapeutic anticoagulation without INR optimisation.
- Inability to provide informed consent (mandatory genetic counselling required).
- Seek emergency care if you experience severe muscle weakness, palpitations, tetany, or fainting while awaiting results.
Patient FAQ & Clinical Guidance
1. What does the SLC12A3 genetic test detect?
Answer: The test identifies pathogenic variants in the SLC12A3 gene responsible for Gitelman syndrome, a hereditary kidney disorder causing salt and electrolyte imbalance. Full gene sequencing ensures detection of both common and rare mutations.
2. How is the sample collected and what is the turnaround time?
Answer: A DHA‑licensed phlebotomist collects a whole blood sample during a scheduled home visit (VIP Mobile Phlebotomy). Results are delivered within 3–4 weeks from sample receipt in the laboratory.
3. Is genetic counselling included?
Answer: Pre‑ and post‑test genetic counselling is mandatory as per Federal Decree‑Law No. 4 of 2016 on Medical Liability and DHA guidelines, ensuring fully informed consent and family pedigree analysis.
4. Can I eat or drink before the blood draw?
Answer: No special fasting is required for this genetic test. However, maintain adequate hydration and inform the phlebotomist of any medications you are currently taking.
5. Will my insurance cover the test cost?
Answer: We offer direct billing verification through your insurer. Send your policy details via WhatsApp to +971 54 548 8731 to confirm coverage before scheduling.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
- Data Protection: Compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) for all patient genomic and clinical data.
- Health Information Governance: Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability & Consent: Genetic counselling and informed consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Quality Certification: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | SLC12A3 Gene Gitelman Syndrome Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral Venous) – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM – 11 PM |
| Methodology Used | Next Generation Sequencing (NGS) with copy number variation analysis |
| ICD-10-CM Code | N15.1 |
| LOINC Code | 94734-5 |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians